// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Impact of Neoadjuvant Therapy on Postoperative Pancreatic Fistula: A Systematic Review and Meta-analysis

J. Oo - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Gastroparesis

N/A

Outcomes in Hilar Cholangiocarcinoma Management through a Clinical Pathway Implementation: A 30-year Single Centre Experience

F. Giovinazzo - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Klatskin tumors

N/A

Is There a Role for Selective Histological Examination of Gallbladders Following Cholecystectomy for Benign Gallbladder Disease? Results of S-GALLOP Study

I. Enemosah - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Gallbladder disease

N/A

The Outcomes of Laparoscopic Common Bile Duct Exploration and Cholecystectomy: Results from a Prospective Multi-centre Cohort Study (The Choles Study)

S. Aroori - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

What Are the Long-term Clinical and Economic Consequences of Delayed Biliary Strictures after Cholecystectomy?

J. Halle-Smith - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Is MELD Score the Best Method of Predicting Waiting List Mortality in the Australian and New Zealand Liver Transplant Population?

E. Lee - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Flip the Liver for Segment 7 Resection

C. Kümmerli - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Temporary Mesenteric-Portal Shunt Using Prosthetic Graft Together with Intermittent Superior Mesenteric Artery Clamping (Pringle-Like) during Complex Venous Resction/Reconstruction in Pancreaticoduodenctomy for Locally Advanced Pancreatic Tumours

M. Ghallab - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Meta-Analysis of Survival Following Pulmonary Resection for Colorectal Cancer Metastases

B. Ratnayake - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal Cancer

N/A

Indeterminate Liver Lesions - A Virtual Epidemic: A Cohort Study over 8 Years

L.L. Kuan - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Emergency Right Hemihepatectomy and Resection of Retroperitoneal Masses to Control Refractory Hypoglycemia from Metastatic Insulinoma Presenting 14 Years after Resection of Non-functioning Pancreatic Neuroendocrine Tumour

N. Kumar - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Peri-operative Epidural Analgesia Offers No Oncological Benefit Following Open Resection of Colorectal Liver Metastases: Long Term Follow up of Two Randomized Controlled Trials

M. Hughes - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Colorectal liver metastases

N/A

High Mobility Group Box 1 Level Is Associated with Long Term Survival Following Liver Resection for Colorectal Liver Metastases

M. Hughes - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Colorectal liver metastases

N/A

Liver-first versus Classical Strategy for Synchronous Colorectal Liver Metastases: An Updated Meta-analysis

D. Zacharoulis - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Colorectal liver metastases

N/A

Long-Term Survival after Liver Resection for Colorectal Liver Metastases: A Retrospective Single-Centre Study with 10-Year Follow-Up

G.R. Nana - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Colorectal liver metastases

N/A

Early Results of Liver Resection and Role of Extended Histology (LIREcH) Study

U. Mathuram Thiyagarajan - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Colorectal liver metastases

N/A

Is a R0 Resection Always the Aim in Resection of Colorectal Liver Metastasis?

M. Stott - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Colorectal liver metastases

N/A

Systematic Review Comparing the Effectiveness of Robotic Verse Laparoscopic Liver Surgery in Colorectal Liver Metastasis (CRLM)

N. Merali - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Colorectal liver metastases

N/A

Follow up after Liver Resection for Colorectal Liver Metastases - How Long Is Long enough?

N. Kumar - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Colorectal liver metastases

N/A

Liver First Approach - Comparative Analysis of Surgical and Oncological Outcomes Using Propensity Score Matching

P. Zelga - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved